| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels
|
Wilk, C. Matthias
|
|
|
6 |
15 |
p. 4485-4489
|
artikel
|
| 2 |
Akhmetzyanova I, Aaron T, Galbo P, et al. Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα. Blood Adv. 2021;5(18):3592-3608.
|
|
|
|
6 |
15 |
p. 4490
|
artikel
|
| 3 |
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies
|
Lynch Jr, Donald R.
|
|
|
6 |
15 |
p. 4645-4656
|
artikel
|
| 4 |
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
|
Candeloro, Matteo
|
|
|
6 |
15 |
p. 4516-4523
|
artikel
|
| 5 |
CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
|
Wang, Chunxu
|
|
|
6 |
15 |
p. 4617-4633
|
artikel
|
| 6 |
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy
|
Cordero-Sanchez, Celia
|
|
|
6 |
15 |
p. 4471-4484
|
artikel
|
| 7 |
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations
|
Drazer, Michael W.
|
|
|
6 |
15 |
p. 4357-4359
|
artikel
|
| 8 |
COVID-19 and venous thromboembolism risk in patients with sickle cell disease
|
Singh, Ashima
|
|
|
6 |
15 |
p. 4408-4412
|
artikel
|
| 9 |
Defective VWF secretion due to expression of MYH9-RD E1841K mutant in endothelial cells disrupts hemostasis
|
Cao, Yang
|
|
|
6 |
15 |
p. 4537-4552
|
artikel
|
| 10 |
Depth of response and response kinetics of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma
|
Martin, Thomas
|
|
|
6 |
15 |
p. 4506-4515
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
6 |
15 |
p. i
|
artikel
|
| 12 |
Enhanced systemic antilymphoma immune response by photothermal therapy with CpG deoxynucleotide–coated nanoparticles
|
Lin, Adam Yuh
|
|
|
6 |
15 |
p. 4581-4592
|
artikel
|
| 13 |
Etra A, Gergoudis S, Morales G, et al. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Adv. 2022;6(12):3707-3715.
|
|
|
|
6 |
15 |
p. 4437-4438
|
artikel
|
| 14 |
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis
|
Luan, Danny
|
|
|
6 |
15 |
p. 4413-4423
|
artikel
|
| 15 |
GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12
|
Zhao, Xuefei
|
|
|
6 |
15 |
p. 4524-4536
|
artikel
|
| 16 |
Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission
|
Jentzsch, Madlen
|
|
|
6 |
15 |
p. 4570-4580
|
artikel
|
| 17 |
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant
|
Jimenez Jimenez, Antonio
|
|
|
6 |
15 |
p. 4491-4500
|
artikel
|
| 18 |
Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice
|
Ren, Guohui
|
|
|
6 |
15 |
p. 4403-4407
|
artikel
|
| 19 |
Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
|
Nishiwaki, Satoshi
|
|
|
6 |
15 |
p. 4558-4569
|
artikel
|
| 20 |
In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
|
Wang, Hongjie
|
|
|
6 |
15 |
p. 4360-4372
|
artikel
|
| 21 |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study
|
Jang, Jun Ho
|
|
|
6 |
15 |
p. 4450-4460
|
artikel
|
| 22 |
Koh MJ, Merrill MH, Koh MJ, et al. Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas. Blood Adv. 2022;6(5):1420-1431.
|
|
|
|
6 |
15 |
p. 4436
|
artikel
|
| 23 |
Longitudinal study of glomerular hyperfiltration in adults with sickle cell anemia: a multicenter pooled analysis
|
Ataga, Kenneth I.
|
|
|
6 |
15 |
p. 4461-4470
|
artikel
|
| 24 |
Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
|
Kim, Haesook T.
|
|
|
6 |
15 |
p. 4392-4402
|
artikel
|
| 25 |
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
|
Wells, Philip S.
|
|
|
6 |
15 |
p. 4605-4616
|
artikel
|
| 26 |
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma
|
Cuffel, Alexis
|
|
|
6 |
15 |
p. 4657-4660
|
artikel
|
| 27 |
Refining the migration and engraftment of short-term and long-term HSCs by enhancing homing-specific adhesion mechanisms
|
Al-Amoodi, Asma S.
|
|
|
6 |
15 |
p. 4373-4391
|
artikel
|
| 28 |
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
|
Baech, Joachim
|
|
|
6 |
15 |
p. 4427-4435
|
artikel
|
| 29 |
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort
|
Scalzulli, Emilia
|
|
|
6 |
15 |
p. 4424-4426
|
artikel
|
| 30 |
Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors
|
Wu, Chenyan
|
|
|
6 |
15 |
p. 4439-4449
|
artikel
|
| 31 |
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
|
Tabanelli, Valentina
|
|
|
6 |
15 |
p. 4634-4644
|
artikel
|
| 32 |
Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
|
Tromp, Samantha A.M.
|
|
|
6 |
15 |
p. 4501-4505
|
artikel
|
| 33 |
Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians
|
Jadhao, Sudhir
|
|
|
6 |
15 |
p. 4593-4604
|
artikel
|
| 34 |
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
|
Thompson, Meghan C.
|
|
|
6 |
15 |
p. 4553-4557
|
artikel
|
Tijdschrift beschrijving